Blog

Different Engagement Models for Partnering with XenoSTART

Partnering with XenoSTART for Preclinical Studies: What Engagement Model is Right for You? Preclinical studies serve as the bridge between

Read more   →

Sourcing Better PDX Models with a Streamlined “Clinic-to-Bench” Pipeline

Discover how XenoSTART’s clinic-to-bench pipeline delivers more clinically relevant PDX models, real-world patient data, and accelerated drug development. Patient-derived xenograft

Read more   →
Thomas' Patient Story

Together in the Fight Against Cancer: Thomas’ Story of Community and Care

“I was thinking about this the other night, one of the things that changed was I stopped flossing, because I

Read more   →
Malignant Hematology Blog Banner

Breaking Barriers in Blood Cancer Treatment: Insights on the Future of Malignant Hematology

A recent START webinar titled Malignant Hematology: Advancing Treatment in Blood Cancers, provided an in-depth look into the current advancements

Read more   →
Advancing ADC Development

Advancing ADC Development: Expert Panel Explores Current Landscape and Future Opportunities

Antibody-drug conjugates (ADCs) are among the most promising innovations in cancer treatment today, combining the targeting precision of monoclonal antibodies

Read more   →
Dr. Moreno Wearables Blog

Wearable Technology in Early-Phase Cancer Trials: Advancing Objective Performance Measures

The integration of wearable technology into early-phase cancer trials represents a pivotal moment in oncology research, offering the ability to

Read more   →
Partnership

Quis volutpat scelerisque quis massa in dolor nunc lectus cursus.

Varius nec, elit turpis amet, proin ut sed nec donec auctor dolor arcu, sollicitudin.

Contact Us
Enim nulla elementum sodales dapibus orci, sed quam mattis aliquam dui penatibus aliquet feugiat nisl laoreet placerat pellentesque duis semper pellentesque tempor placerat nam parturient magna volutpat auctor mattis imperdiet sapien ut tortor id amet tempor tortor, augue facilisi mi.